220 related articles for article (PubMed ID: 2783712)
1. Specific detection of antibodies in cancer patients following immunotherapy with anti-idiotype.
Wettendorff M; Iliopoulos D; Schmoll E; Koprowski H; Herlyn D
J Immunol Methods; 1989 Jan; 116(1):105-15. PubMed ID: 2783712
[TBL] [Abstract][Full Text] [Related]
2. Anti-idiotypic antibody (ab2) vaccines: coupling of Ab2 BR3E4 to KLH increases humoral and/or cellular immune responses in animals and colorectal cancer patients.
Birebent B; Koido T; Mitchell E; Li W; Somasundaram R; Purev E; Hoey D; Mastrangelo M; Maguire H; Harris DT; Nair S; Cai E; Herlyn D
J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R27-33. PubMed ID: 11768621
[TBL] [Abstract][Full Text] [Related]
3. Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A.
Herlyn D; Ross AH; Iliopoulos D; Koprowski H
Eur J Immunol; 1987 Nov; 17(11):1649-52. PubMed ID: 3500066
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory activity of monoclonal anti-idiotypic antibody to anti-colorectal carcinoma antibody CO17-1A in animals and patients.
Herlyn D; Harris D; Zaloudik J; Sperlagh M; Maruyama H; Jacob L; Kieny MP; Scheck S; Somasundaram R; Hart E
J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):303-11. PubMed ID: 8061902
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cancer patients' immune responses by anti-idiotypic antibodies.
Herlyn D; Wettendorff M; Koprowski H
Int Rev Immunol; 1989; 4(4):347-57. PubMed ID: 2519932
[TBL] [Abstract][Full Text] [Related]
6. Anti-idiotype immunization of cancer patients: modulation of the immune response.
Herlyn D; Wettendorff M; Schmoll E; Iliopoulos D; Schedel I; Dreikhausen U; Raab R; Ross AH; Jaksche H; Scriba M
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8055-9. PubMed ID: 3500471
[TBL] [Abstract][Full Text] [Related]
7. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Maruyama H; Zaloudik J; Li W; Sperlagh M; Koido T; Somasundaram R; Scheck S; Prewett M; Herlyn D
Cancer Immunol Immunother; 2000 Jun; 49(3):123-32. PubMed ID: 10881691
[TBL] [Abstract][Full Text] [Related]
8. Induction of anti-idiotypic (ab2) and anti-anti-idiotypic (ab3) antibodies in patients treated with the mouse monoclonal antibody 17-1A (ab1). Relation to the clinical outcome--an important antitumoral effector function?
Frödin JE; Faxas ME; Hagström B; Lefvert AK; Masucci G; Nilsson B; Steinitz M; Unger P; Mellstedt H
Hybridoma; 1991 Aug; 10(4):421-31. PubMed ID: 1937495
[TBL] [Abstract][Full Text] [Related]
9. Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1A.
Wettendorff M; Iliopoulos D; Tempero M; Kay D; DeFreitas E; Koprowski H; Herlyn D
Proc Natl Acad Sci U S A; 1989 May; 86(10):3787-91. PubMed ID: 2786203
[TBL] [Abstract][Full Text] [Related]
10. Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen.
Bhattacharya-Chatterjee M; Mukerjee S; Biddle W; Foon KA; Köhler H
J Immunol; 1990 Oct; 145(8):2758-65. PubMed ID: 1698862
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific idiotype vaccines. I. Generation and characterization of internal image tumor antigen.
Raychaudhuri S; Saeki Y; Fuji H; Kohler H
J Immunol; 1986 Sep; 137(5):1743-9. PubMed ID: 3018080
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the anti-idiotypic responses generated by antibodies to a protein and a hapten: a common interspecies idiotype on antibodies against human albumin induces an idiotypic network in rabbits.
Comacchio RM; Bradley J; Hohmann AW
Immunol Cell Biol; 1996 Feb; 74(1):72-80. PubMed ID: 8934657
[TBL] [Abstract][Full Text] [Related]
13. Anti-idiotype and recombinant antigen in immunotherapy of colorectal cancer.
Herlyn D; Somasundaram R; Zaloudik J; Jacob L; Harris D; Kieny MP; Sears H; Mastrangelo M
Cell Biophys; 1994; 24-25():143-53. PubMed ID: 7736518
[TBL] [Abstract][Full Text] [Related]
14. Anti-idiotype cancer vaccines: pre-clinical and clinical studies.
Herlyn D; Benden A; Kane M; Somasundaram R; Zaloudik J; Sperlagh M; Marks G; Hart E; Ralph C; Wettendorff M
In Vivo; 1991; 5(6):615-23. PubMed ID: 1810448
[TBL] [Abstract][Full Text] [Related]
15. Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy?
Fagerberg J; Frödin JE; Ragnhammar P; Steinitz M; Wigzell H; Mellstedt H
Cancer Immunol Immunother; 1994 Mar; 38(3):149-59. PubMed ID: 8124683
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen.
Li G; Hu J; Zhou G; Zhu J; Sun Q
Chin Med J (Engl); 2001 Sep; 114(9):962-6. PubMed ID: 11780392
[TBL] [Abstract][Full Text] [Related]
17. Polyclonal anti-idiotypic antibodies mimicking the small cell lung carcinoma antigen cluster-5A interact with a panel of antibodies and induce specific immune response in animals.
Zwicky C; Stahel RA; Jaksche H; Waibel R; Lehmann HP; Loibner H
Br J Cancer Suppl; 1991 Jun; 14():67-70. PubMed ID: 1645576
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II (AII)-related idiotypic network. II. Heterogeneity and fine specificity of AII internal images analyzed with monoclonal antibodies.
Budisavljevic M; Geniteau-Legendre M; Baudouin B; Pontillon F; Verroust PJ; Ronco PM
J Immunol; 1988 May; 140(9):3059-65. PubMed ID: 2452197
[TBL] [Abstract][Full Text] [Related]
19. CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphoma.
Pohl C; Renner C; Schwonzen M; Schobert I; Liebenberg V; Jung W; Wolf J; Pfreundschuh M; Diehl V
Int J Cancer; 1993 May; 54(3):418-25. PubMed ID: 8389737
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta).
Raychaudhuri S; Saeki Y; Chen JJ; Iribe H; Fuji H; Kohler H
J Immunol; 1987 Jul; 139(1):271-8. PubMed ID: 2953815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
